Evidence map›Paper›PMID 41884793›Full record

ArticleTherapeutic advances in infectious disease

Chronic pulmonary aspergillosis and pulmonary embolism/venous thromboembolism: a case series and systematic review of the literature.

Joseph Baruch Baluku, Peter Isagara, Ivaan Pitua, Jeremiah Mutinye Kwesiga, Judith Mutesi, Joanitah Nalunjogi, Ahmed Ddungu, Ronald Olum, Felix Bongomin

Abstract readCase Reports
In one paragraph

Article in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Joseph Baruch BalukuDivision of Pulmonology, Kiruddu National Referral Hospital, P.O. Box 26343, Kampala, Uganda.ORCID https://orcid.org/0000-0002-5852-9674
Peter IsagaraDivision of Pulmonology, Kiruddu National Referral Hospital, Kampala, Uganda.ORCID https://orcid.org/0009-0001-4381-7761
Ivaan PituaSchool of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.ORCID https://orcid.org/0000-0003-0768-1315
Jeremiah Mutinye KwesigaDepartment of Psychiatry, Makerere University College of Health Sciences, Kampala, Uganda.ORCID https://orcid.org/0000-0001-5507-1664
Judith MutesiDivision of Pulmonology, Kiruddu National Referral Hospital, Kampala, Uganda.
Joanitah NalunjogiTuberculosis Research Group, Makerere University Lung Institute, Kampala, Uganda.
Ahmed DdunguTuberculosis Research Group, Makerere University Lung Institute, Kampala, Uganda.
Ronald OlumJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0003-1289-0111
Felix BongominDepartment of Medical Microbiology & Immunology, Faculty of Medicine, Gulu University, Gulu, Uganda.ORCID https://orcid.org/0000-0003-4515-8517

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic pulmonary aspergillosis (CPA) often arises in the setting of structural lung damage and is associated with chronic inflammation, which increases the risk of venous thromboembolic disease (VTE), including pulmonary embolism (PE). However, the clinical context and pathophysiological mechanisms underlying CPA/VTE remain poorly defined. This study aims to highlight the clinical challenges through a case series and systematic review of existing literature regarding this rare co-occurrence. We present three complex cases from Kiruddu National Referral Hospital in Uganda: two males, one female, aged 44-80 years, with post-tuberculosis lung disease. All three were diagnosed with

Indexed as

case serieschronic pulmonary aspergillosisCPAdeep venous thromboembolismpulmonary embolism

Identifiers

PMID41884793
PMCPMC13010053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.